2007
DOI: 10.1002/0471142301.ns0924s39
|View full text |Cite
|
Sign up to set email alerts
|

Overview of Animal Models of Schizophrenia

Abstract: Animal models of schizophrenia may increase the understanding of the neurological abnormalities associated with the disorder and aid in the development of rational pharmacological treatments. Rather than attempting to model the entire syndrome of schizophrenia, a more biologically oriented approach to animal models has been to focus on specific symptoms of schizophrenia that are more objectively measured in the clinical population and more directly translatable to animals (e.g., observables or endophenotypes).… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
24
0

Year Published

2009
2009
2016
2016

Publication Types

Select...
5
3
2

Relationship

2
8

Authors

Journals

citations
Cited by 29 publications
(25 citation statements)
references
References 188 publications
(235 reference statements)
0
24
0
Order By: Relevance
“…50 Disruption of sensorimotor gating by amphetamine is commonly used as a behavioural paradigm to model psychosis in rodents, and this effect can be blocked by antipsychotics. 72 Since Akt1 is inhibited following the stimulation of D2 receptors, the increased behavioural effect of amphetamine in Akt1 knockout mice supports the involvement of Akt inhibition in DArelated behavioural responses. However, DA regulates more than locomotion and sensorimotor gating.…”
Section: Regulation Of Behaviour By the D2 Receptorβarr2 -Akt-gsk3 Simentioning
confidence: 85%
“…50 Disruption of sensorimotor gating by amphetamine is commonly used as a behavioural paradigm to model psychosis in rodents, and this effect can be blocked by antipsychotics. 72 Since Akt1 is inhibited following the stimulation of D2 receptors, the increased behavioural effect of amphetamine in Akt1 knockout mice supports the involvement of Akt inhibition in DArelated behavioural responses. However, DA regulates more than locomotion and sensorimotor gating.…”
Section: Regulation Of Behaviour By the D2 Receptorβarr2 -Akt-gsk3 Simentioning
confidence: 85%
“…AMPH-and PCP-induced hyperlocomotion are the two commonly used pharmacological models to test APD efficacy. Most APDs are D2R partial agonists or antagonists with varying potencies and efficacies (31,32,40,58) and inhibit either the AMPH-or PCP-induced locomotor response in mice (59). The AMPH-induced locomotor response is dependent on striatal DA release, whereas the behavioral effects of PCP are thought to be mediated by cortical disinhibition and activation of the corticostriatal pathway (48,50).…”
Section: Region-specific Responses Of Antipsychotics and βArr2-biasedmentioning
confidence: 99%
“…In order to bridge the translational gap, tests used in animal models have also been considered and selected for future use and development (Gilmour et al, 2012; Lustig et al, 2012). Domains such as verbal learning and memory cannot be translated to rodents, however processes such as attention, memory and executive control can be measured in a number of ways (Powell and Geyer, 2007) The tests selected for rodents that best reflect the cognitive constructs measured in patients include the five choice serial reaction time task (5C-SRTT) (Robbins, 2002) and sustained attention task (dSAT) for measuring attention (Lustig et al, 2012), the attentional set-shifting task (ASST) (Birrell and Brown, 2000) and reversal learning (Izquierdo and Jentsch, 2012) as measures of executive control and the radial arm maze (RAM) and delayed match to position (DMTP) task (Dudchenko, 2004), which provide the best assessment of working memory.…”
Section: Modeling the Cognitive Deficits In Schizophreniamentioning
confidence: 99%